Dr. Andrew M. Blumenfeld M.D.

Expert Publications

• Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
• An integrated management program for migraine: the Kaiser experience.
• A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
• The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics.
• Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
• Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).
• Acute autonomic neuropathy with Salmonella typhi infection. A case report.
• The importance of carotid artery plaque disruption and hemorrhage.
• Probable chloroquine-resistant Plasmodium falciparum malaria in south-western Africa.

Media Releases

Dr. Blumenfeld is a neurologist and neurocritical care physician. He has been a principal investigator for many research studies showing that Botulinum toxin type A, sold under the brand name Botox®, is an effective preventative therapy for headache in chronic migraine sufferers. He has treated more patients with Botox therapy than any other provider in the world and trains other physicians on this - both nationally and internationally.

Dr. Blumenfeld is the Director of the Headache Center of Southern California, whose mission is to provide excellent, comprehensive headache care. As director, he focuses on addressing the multi-faceted needs of headache sufferers. These needs include acute care, educational programs, and other specialty services. This comprehensive approach treats the whole person in a highly individualized manner and addresses the growing demand for one-stop treatment services.

Dr. Blumenfeld currently holds active privileges at Scripps Memorial Hospitals (Encinitas and La Jolla) and the Tri-City Medical Center in Oceanside, California.

Dr. Blumenfeld grew up in South Africa and graduated from St. Andrews College, South Africa, with a first class pass and distinction in mathematics. He then went on to receive his medical degree from the University of the Witwatersrand, Johannesburg, after which he completed a residency in neurology at Johannesburg Hospital. In 1986, he moved to the United States and completed a residency in neurology at the University of Massachusetts Medical School. Following this, Dr. Blumenfeld completed his fellowship training in neurophysiology, also at the University of Massachusetts Medical School.

Dr. Blumenfeld served as staff neurologist at Kaiser Permanente, San Diego from 1990 to 2004. As Chief of Neurology Service at Kaiser from 1999-2004, his unit was named a Neurotoxin Center of Excellence by Thomas Jefferson University and Jefferson Medical College. The Neurotoxin Centers of Excellence recognize excellence in neurologists and other physicians who specialize in headache management.

Dr Blumenfeld is a member of the American Academy of Neurology and the American Headache Society. He has published widely and has been an active researcher in headaches and multiple sclerosis.

Dr. Blumenfeld serves on the advisory board for Allergan. He has been a national speaker and consultant for Allergan, as well as other well-known medical corporations: Pfizer, GSK, Merck, Posen, Zogenix, MAP pharmaceuticals, Forrest, and Ortho McNeill.

Dr. Blumenfeld is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the public interest and the professions of psychiatry and neurology by promoting excellence in practice through certification and continuing certification processes.

Neurology is the branch of medicine concerned with the study and treatment of disorders of the nervous system. Neurocritical care is a medical field that treats life-threatening diseases of the nervous system and identifies, prevents/treats secondary brain injury. Being a neurologist and neurocritical care physician, Dr. Blumenfeld provides emergency critical care for patients with serious conditions involving the nervous system, brainstem or brain. He also treats secondary injuries of the brain, such as those brought on by chronic illnesses.

Dr. Blumenfeld is an avid bicyclist, having participated in the Race Across America in 2003 and 2004. In his spare time, he enjoys running and spending time with his family.

Recommended Articles

• What Does Trypophobia Do to the Brain?

  Trypophobia is a term that was created way back to refer to a certain kind of phobia. It is not an official name and you can’t even find it in the official list of phobias. However, the kind of phobia that this term is used to refer to is as real and as natural as it gets. That should explain why...

• In Plain Sight: Vision Changes Linked to Parkinson’s Disease

  Parkinson’s disease is a chronic, progressive movement disorder that affects the nervous system. It is characterized by gradual death and breakdown of nerve cells in the brain resulting in the decreased production of a chemical messenger called dopamine. Reduced dopamine levels cause abnormal...

• Author Greg O'Brien Speaks About his Emotions Hijacked by Alzheimer's

  There are different types of memory related illnesses, something that many people know all too well unfortunately. Author and former newspaper editor Greg O’ Brien is one of them. He has spoken out about his experience with Alzheimer’s disease and how it has certainly impacted his life and those...

• Wrigley Field Comes Under Fire After Cubs Fan Sues for Violating Disabilities Act

  David F. Cerda has been wheelchair-bound ever since he was 10 years old. This was caused by muscular dystrophy. Muscular dystrophy is a disease that affects the muscular and skeletal system by weakening the muscles and causing the loss of muscular mass. Mutations or abnormal genes in the muscle...

• Predicting Cognitive Decline in Parkinson’s Disease

  More than one million Americans (more than 6 million people in the whole world) suffer from Parkinson’s disease affecting them and their loved ones directly on a daily basis. A cure for this condition has not been discovered yet, nevertheless it can be controlled effectively if it is watched...

• CRISPR Could be the Possible Cure for Muscular Dystrophy

  How about technology that could offer a “cut and paste” or just a “delete” solution to all genetic mutations, defects, and resulting disorders? Well, that may sound too much to ask for, an oversimplification, but it is exactly what many scientific researchers in the field of genetic modeling...